1Dr. J. M. Lundberg,T. H?kfelt,C. -R. Martling,A. Saria,C. Cuello. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man[J] 1984,Cell and Tissue Research(2):251～261
5Mac Nee W.Pathogenesis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med,2005(2):258-266.
6Groneberg D A,Quarcoo D,Frossard N,et al.Neurogenic mechanisms in bronchial inflammatory diseases.Allergy, 2004,59(11):1139-1152.
7Guidelines:Executive Summary:Global Strategy for the Diagnosis,Management,and Prevention of COPD,December 2009.
8Jacques Rizkallah,S.F.Paul Man and Don D.Sin.Prevalence of Pulmonary Embolism in Acute Exacerbations of COPD. Chest,2009,135:786-793.
9Bames PJ. Neuropeptides and asthma. Am Res Respir Dis, 1991,143(1) : 28.
10Wang X, Jones SB, Zhou Z, et al. Caicitoin genrelated peptide (CGRP) and neuropeptide Y (NPY)levels are elevated in plasma and decreased in vein cave during endotoxic shock in the rat. Cir Shock,1992,36(1) : 21.
